Trial Profile
Phase I trial of NLX E201, a gene therapy for the treatment of epilepsy
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 03 Apr 2008
Price :
$35
*
At a glance
- Drugs NLX E201 (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- 07 Dec 2007 Neurologix has received a grant from the Epilepsy Research Foundation and will use it to fund this trial which is expected to begin in early 2008.
- 15 Nov 2007 New trial record.